Prevalence and predictive factors of long COVID in nurses in Brazil
摘要
The coronavirus disease 2019 (COVID-19) pandemic has posed significant challenges to global public health, particularly affecting nursing professionals, owing to their continuous exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and intense working conditions. This study aims to analyze the frequency and predictors of symptoms persisting for 4 weeks or more after COVID-19 among Brazilian nurses, examining associations with situational and clinical variables.
MethodsA cross-sectional study was conducted involving 3,155 nurses from all macroregions of Brazil who tested positive for COVID-19, of whom 1,921 reported persistent symptoms lasting four weeks or more due to COVID-19. Data collection included sociodemographic, situational, and clinical variables. The statistical tests chi-square was applied to assess differences between independent variables and symptom persistence. Additionally, in order to assess associations between the outcome variable and independent variables a logistic regression were applied. Finally co-occurrence analysis and the Jaccard index were used to identify patterns associated with persistency of COVID-19 symptoms.
ResultsThe study consisted of 3,155 nurses, predominantly female (84.0%). The prevalence of symptoms persisting for four weeks or longer after COVID-19 through the sample was 60,9%. Chronic conditions were reported by 33.0% of the participants, the most common persistent symptoms included fatigue (70.0%), memory loss (68.8%). Statistically significant associations were observed between long COVID-19 duration and the presence of comorbidities, especially rhinitis and obesity (p < 0.01). Cooccurrence analysis revealed strong correlations between cough and memory loss (Jaccard = 0.980), insomnia and loss of taste (0.978).
ConclusionsThe findings highlight the complexity of COVID-19 among Brazilian nurses and identify clinical and sociodemographic factors associated with persistent symptoms, informing strategies to support affected healthcare professionals.
Clinical trial numberNot applicable.